Propharmacyny
About Propharmacyny
Propharmacyny is a Healthcare company based in United States, and was acquired by Penta Investments in October 2017. Prescription services and home delivery are provided nationwide. Its focus areas include Pharmacies.
Company details
Prescription fulfillment, patient care, and support for insurance and medication costs are handled by Propharmacyny in the pharmacy sector. Home delivery options are available to customers across the United States. Coordination with prescribers and insurers is managed to facilitate efficient operations. Standard services include quick processing of prescriptions and assistance with financial aspects of healthcare needs.
- Headquarters United States
- Stage Acquired
- SectorsHealthcare
- Website propharmacyny.com
- Acquired by Penta Investments (Oct 2017)
- Investors
- Acquired byPenta Investments
(Oct 2017)
Investors in Propharmacyny
Propharmacyny has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Penta Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Penta Investments is focused on long-term value investments. | pentainvestments.com | Prague, Czech Republic |
Investor details for Propharmacyny
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Propharmacyny
The website of Propharmacyny (propharmacyny.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 253.7% vs previous month
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Propharmacyny (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Propharmacyny
Propharmacyny is headquartered in United States.
Prescription fulfillment, patient care, and support for insurance and medication costs are handled by Propharmacyny in the pharmacy sector. Home delivery options are available to customers across the United States. Coordination with prescribers and insurers is managed to facilitate efficient operations. Standard services include quick processing of prescriptions and assistance with financial aspects of healthcare needs.
Propharmacyny has 1 investor. Key investors include Penta Investments.
Yes. Propharmacyny was acquired by Penta Investments in October 2017.